PARAGON 28 INC (FNA) Stock Price, Forecast & Analysis
USA - NYSE:FNA - US69913P1057 - Common Stock
FNA Key Statistics, Chart & Performance
The current stock price of FNA is 13.09 USD. In the past month the price increased by 0.46%. In the past year, price increased by 33.57%.
FNA Latest News, Press Relases and Analysis
FNA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.09 | 217.91B | ||
| ISRG | INTUITIVE SURGICAL INC | 65.86 | 203.29B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.86 | 148.00B | ||
| SYK | STRYKER CORP | 26.76 | 134.76B | ||
| IDXX | IDEXX LABORATORIES INC | 55.66 | 56.15B | ||
| BDX | BECTON DICKINSON AND CO | 12.36 | 51.10B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.44 | 48.95B | ||
| RMD | RESMED INC | 25.14 | 36.32B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 15.8 | 33.12B | ||
| PODD | INSULET CORP | 69.73 | 22.43B | ||
| DXCM | DEXCOM INC | 29.41 | 21.45B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.78 | 17.27B |
Related stock screener links
About FNA
Company Profile
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 525 full-time employees. The company went IPO on 2021-10-21. The firm provides orthopedic solutions, procedural approaches and instrumentation that cover a range of foot and ankle ailments, including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. To treat these painful, debilitating or even life-threatening conditions, it provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Its broad suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. The company has developed a comprehensive portfolio of foot and ankle surgical systems. Each system typically includes plates, screws, staples, nails, advanced joint and bone replacements, orthobiologics, and other implantation instruments and disposables specifically designed for the particular surgical system.
Company Info
PARAGON 28 INC
14445 Grasslands Drive
Englewood COLORADO US
Employees: 574
Phone: 17209121332
PARAGON 28 INC / FNA FAQ
What does FNA do?
Paragon 28, Inc. engages in operation of an orthopedic foot and ankle company. The company is headquartered in Englewood, Colorado and currently employs 525 full-time employees. The company went IPO on 2021-10-21. The firm provides orthopedic solutions, procedural approaches and instrumentation that cover a range of foot and ankle ailments, including fracture fixation, forefoot, ankle, progressive collapsing foot deformity (PCFD) or flatfoot, Charcot foot and orthobiologics. To treat these painful, debilitating or even life-threatening conditions, it provides a portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. Its broad suite of surgical solutions comprises nearly 80 product systems to help fit the specific needs of each patient and procedure. The company has developed a comprehensive portfolio of foot and ankle surgical systems. Each system typically includes plates, screws, staples, nails, advanced joint and bone replacements, orthobiologics, and other implantation instruments and disposables specifically designed for the particular surgical system.
What is the stock price of PARAGON 28 INC today?
The current stock price of FNA is 13.09 USD.
Does FNA stock pay dividends?
FNA does not pay a dividend.
How is the ChartMill rating for PARAGON 28 INC?
FNA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Can you provide the PE ratio for FNA stock?
PARAGON 28 INC (FNA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.63).
When does PARAGON 28 INC (FNA) report earnings?
PARAGON 28 INC (FNA) will report earnings on 2025-05-08, after the market close.
FNA Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to FNA. When comparing the yearly performance of all stocks, FNA is one of the better performing stocks in the market, outperforming 93.33% of all stocks.
FNA Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to FNA. While FNA seems to be doing ok healthwise, there are quite some concerns on its profitability.
FNA Financial Highlights
Over the last trailing twelve months FNA reported a non-GAAP Earnings per Share(EPS) of -0.63. The EPS decreased by -10.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -18.79% | ||
| ROE | -41.84% | ||
| Debt/Equity | 0.84 |
FNA Forecast & Estimates
10 analysts have analysed FNA and the average price target is 14.28 USD. This implies a price increase of 9.09% is expected in the next year compared to the current price of 13.09.
For the next year, analysts expect an EPS growth of 25.22% and a revenue growth 14.16% for FNA